Drugs / Treg
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02991898 | Feb 2017 → Jun 2019 | Burkitt lymphoma, Hodgkins lymphoma, T-cell and NK-cell neoplasm, acute biphenotypic leukemia +10 | Masonic Cancer Center, University of Minnesota | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Treg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02991898 ↗ |